ai3Bio launches with $48 million Series A funding
The biotechnology company said the round was led by UPMC Enterprises and Ziff Capital Partners. Proceeds will support IND-enabling studies and first-in-human trials in autoimmune disease.
Site Search
Search market news
Find public news by keyword, exact ticker, category and date.
Matching instruments
Open a ticker page for its news coverage. The news search below stays a text search.